Using AI to improve stroke care in Northern Norway
Improving Stroke Care in North-Norway Through Artificial Intelligence
This study is testing whether an AI tool can help doctors in Northern Norway find and treat patients with certain types of strokes faster and more effectively than using traditional methods.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital of North Norway Academic / other |
| Locations | 1 site (Tromsø) |
| Trial ID | NCT05903898 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of an artificial intelligence support tool, StrokeSens, in enhancing decision-making and detection rates for patients with acute ischemic strokes caused by large or medium vessel occlusions. Conducted across multiple hospitals in Northern Norway, the study compares outcomes between centers using the AI tool and those relying solely on traditional radiological services. The AI software aims to expedite the identification of stroke patients and improve treatment outcomes by analyzing radiological images for ischemic changes and occlusions.
Who should consider this trial
Good fit: Ideal candidates include patients with acute stroke symptoms admitted to participating hospitals within 24 hours of symptom onset.
Not a fit: Patients who are not available for follow-up assessments or are non-residents may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to faster diagnosis and treatment of stroke patients, potentially improving recovery outcomes.
How similar studies have performed: Other studies have shown promise in using AI for medical imaging, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with acute stroke symptoms admitted to a participating hospital within 24 hours of symptom onset Exclusion Criteria: * Patients not available for follow-up assessments (e.g. non-resident)
Where this trial is running
Tromsø
- University Hospital of North Norway — Tromsø, Norway (Recruiting)
Study contacts
- Principal investigator: Agnethe Eltoft — University Hospital of North Norway
- Study coordinator: Agnethe Eltoft, MD, PhD
- Email: agnethe.eltoft@unn.no
- Phone: 004797193417
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.